Theadventoftargeted anti-cancertherapies hasrevolutionised treatmemt of manymalignancies.Following
theparadiqmofpersonalised medicine. moecuartestinqoftumoursisnowroutineinordertoidentifv specific
geneticalterations predictive ofresponsetoparticulartherapies.
WhichofthefollowinaneopLasms mostfreauently respondstospecific tvrosinekinase inhibitors?
Acutetymphocyticleukaemia
Acutemyeloidleukaemia
Chronicvmphocyticueukaemia
Gastrointestinat stromaltumours
Multjple myeoma
@1MIN NDOCRINE
